Cargando…
Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy
Rationale: Combinations of two or more therapeutic agents targeting different signaling pathways involved in tumor progression can have synergistic anticancer effects. However, combination chemotherapies are greatly limited by the different pharmacokinetics, tumor targeting, and cellular uptake capa...
Autores principales: | Zou, Liang, Liu, Xiaowei, Li, Jingjing, Li, Wei, Zhang, Lele, Fu, Chaomei, Zhang, Jinming, Gu, Zhongwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7977472/ https://www.ncbi.nlm.nih.gov/pubmed/33754055 http://dx.doi.org/10.7150/thno.42260 |
Ejemplares similares
-
Tetramethylpyrazine Enhances the Antitumor Effect of Paclitaxel by Inhibiting Angiogenesis and Inducing Apoptosis
por: Zou, Liang, et al.
Publicado: (2019) -
Redox-responsive PEGylated self-assembled prodrug-nanoparticles formed by single disulfide bond bridge periplocymarin-vitamin E conjugate for liver cancer chemotherapy
por: Zhang, Huiyun, et al.
Publicado: (2017) -
A self-assembling nanomedicine of conjugated linoleic acid-paclitaxel conjugate (CLA-PTX) with higher drug loading and carrier-free characteristic
por: Zhong, Ting, et al.
Publicado: (2016) -
Self-Assembled Disulfide Bond Bearing Paclitaxel—Camptothecin Prodrug Nanoparticle for Lung Cancer Therapy
por: Gao, Jingyan, et al.
Publicado: (2020) -
Drug resistance reversal in ovarian cancer cells of paclitaxel and borneol combination therapy mediated by PEG-PAMAM nanoparticles
por: Zou, Liang, et al.
Publicado: (2017)